A newly awarded $820,000 grant from The National Cancer Institute will allow a team of multi-disciplinary investigators to increase clinical trial awareness and participation for rural patients who make up almost half of the area served by Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center.
Post Tagged with: "Norris Cotton Cancer Center"
A new study uncovers how the most commonly mutated tumor suppressor gene in cancer and the most commonly mutated oncogene in cancer cooperate to drive formation of pancreatic cancer.
A $328,000 National Cancer Institute (NCI) grant will enable researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) to investigate one of the mechanisms that may be responsible for the body’s inability to fight COVID-19.
More than 2,500 participants came together virtually between June 1 and July 11 to raise $2,800,000 for Norris Cotton Cancer Center during the Prouty, featuring a variety of activities and participants from around the globe.
A research team at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center has found that the same vaccination programs that target human papillomavirus (hrHPV) strains in the United States may not be as effective in protecting other populations of women from the disease.
$15.5 million NCI grant continues support for northern New England’s only comprehensive center.
Dartmouth researchers have created an AI model to classify colorectal polyps on histology slides. Evaluation using 238 slides from 24 institutions across 13 US states finds that the model performs as well as practicing pathologists.
A common anti-diabetes drug being tested in many clinical trials as an anti-cancer agent activated fat metabolism that promoted the survival of dormant breast cancer cells, suggesting that the drug has context-dependent effects on cancer cells.
Using specialty cameras and an oxygen probe drug injection, researchers at Dartmouth’s Norris Cotton Cancer Center can now image oxygen from within cancer tumors during radiation therapy while the probe is excited by Cherenkov light, a byproduct of radiation.
Researchers led by Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center are studying a valuable target in regulating the immune response in cancer and autoimmunity. VISTA is a tempering molecule that hinders T cells in the immune system from activating against self-antigens such as cancer cells. Their new publication describes how VISTA controls T-cell responses.